| Net revenues | 261.28M |
| Cost of revenues | 140.22M |
| Research and development | 55.25M |
| Selling, general and administrative | 59.75M |
| Acquisition-related charges (credits) | 1.93M |
| Restructuring charges | -850K |
| Asset impairment charges | |
| Loss (gain) on sale of assets | |
| Total operating expenses | 256.3M |
| Income (loss) from operations | 4.98M |
| Interest and other (expense) income, net | 2.62M |
| Income (loss) before income taxes | 7.6M |
| (Provision for) benefit from income taxes | -59.92M |
| Net income (loss) | 4.73M |
| Net income (loss) (in dollars per share) | -0 |
| Weighted-average shares used in basic net income (loss) per share calculations (in shares) | -835.43M |
| Net income (loss) (in dollars per share) | -0 |
| Weighted-average shares used in diluted net income (loss) per share calculations (in shares) | -836.63M |